Skip to content

Evaluation of an app for self-directed processing of therapeutic content for patients with unipolar depression

Evaluation of an app for self-directed processing of therapeutic content for patients with unipolar depression - DAIsy-App

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033782
Enrollment
62
Registered
2024-03-20
Start date
2024-07-29
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32.0 F32.1 F32.2 F33.0 F33.1 F33.2

Interventions

Group 1: Treatment-as-usual patients with unipolar depression independently use one of a total of six available therapy modules in digital form for a four-week intervention phase. Group 2: Treatment-a

Sponsors

Universitätsklinikum Bonn
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Previous diagnosis of unipolar depression by experts or current diagnosis as part of the study assessment Current minimum sum score of 9 on the GRID-HAMD17 rating Ongoing medication, psychotherapy or other S3 guideline-compliant treatment for depression Sufficient understanding of the German language

Exclusion criteria

Exclusion criteria: Signs of increased risk of suicidal tendencies (GRID-HAMD Item 3 score greater than 2) Psychotic symptoms Bipolar disorder/manic symptoms Disorders belonging to the schizophrenia spectrum Substance dependence

Design outcomes

Primary

MeasureTime frame
Change in depression symptoms by means of PHQ-9 following a four-week intervention.

Secondary

MeasureTime frame
Usability measured by the System Usability Scale (SUS) Satisfaction with the digital intervention (CSQ-I) Change in Generalizied Anxiety Disorder Scale (GAD-7) Change in behavioral activation (BADS) Change in subjective perception of stress (PSS) Change in psychological resilience (RS) Change in self-esteem (RSES) Change in bias due to negative interpretation (AST-D-II) Change in subjective quality of life (WHOQoL) Change in depressive symptoms according to ICD-11 criteria (IDQ) Change in anxiety symptoms (IAQ) Subjective assessment of efficacy of the respective modules Survey of adverse events Knowledge transfer of the therapy content

Countries

Germany

Contacts

Public ContactAlexandra Philipsen

Universitätsklinikum Bonn

Sekretariat.Psychiatrie@ukbonn.de0228 287-15723

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026